DRUG METABOLITE CONCENTRATION-TIME PROFILES - INFLUENCE OF ROUTE OF DRUG ADMINISTRATION

被引：33

作者：

HOUSTON, JB ^{[1
]}

TAYLOR, G ^{[1
]}

机构：

[1] UWIST,WELSH SCH PHARM,CARDIFF CF1 3NU,S GLAM,WALES

来源：

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 1984年 / 17卷 / 04期

关键词：

D O I：

10.1111/j.1365-2125.1984.tb02362.x

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：385 / 394

页数：10

共 33 条

[1] 1ST PASS HYDROXYLATION OF NORTRIPTYLINE - CONCENTRATIONS OF PARENT DRUG AND MAJOR METABOLITES IN PLASMA [J].

ALVAN, G ;

BORGA, O ;

LIND, M ;

PALMER, L ;

SIWERS, B .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1977, 11 (03) :219-224

[2] IMPACT OF ACTIVE METABOLITES ON MONITORING PLASMA-CONCENTRATIONS OF THERAPEUTIC DRUGS [J].

ATKINSON, AJ ;

STEC, GP ;

LERTORA, JJL ;

RUO, TI ;

THENOT, JP .

THERAPEUTIC DRUG MONITORING, 1980, 2 (01) :19-27

[3]

BAI SA, 1983, J PHARMACOL EXP THER, V224, P62

[4]

COLLSTE P, 1979, CLIN PHARMACOL THER, V25, P416

[5] KINETIC CONSIDERATIONS RELATING TO ACCRUAL AND ELIMINATION OF DRUG METABOLITES [J].

CUMMINGS, AJ ;

MARTIN, BK ;

PARK, GS .

BRITISH JOURNAL OF PHARMACOLOGY AND CHEMOTHERAPY, 1967, 29 (02) :136-&

[6]

DAHL SG, 1976, CLIN PHARMACOL THER, V19, P435

[7]

DAHL SG, 1977, CLIN PHARMACOL THER, V21, P437

[8] PHARMACOLOGICALLY ACTIVE METABOLITES OF DRUGS AND OTHER FOREIGN COMPOUNDS - CLINICAL, PHARMACOLOGICAL, THERAPEUTIC AND TOXICOLOGICAL CONSIDERATIONS [J].

DRAYER, DE .

DRUGS, 1982, 24 (06) :519-542

[9] PHARMACOLOGICALLY ACTIVE DRUG METABOLITES - THERAPEUTIC AND TOXIC ACTIVITIES, PLASMA AND URINE DATA IN MAN, ACCUMULATION IN RENAL-FAILURE [J].

DRAYER, DE .

CLINICAL PHARMACOKINETICS, 1976, 1 (06) :426-443

[10] COMBINED HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC PROCEDURE FOR MEASURING 4-HYDROXYPROPRANOLOL AND PROPRANOLOL IN PLASMA - PHARMACOKINETIC MEASUREMENTS FOLLOWING CONVENTIONAL AND SLOW-RELEASE PROPRANOLOL ADMINISTRATION [J].

DRUMMER, OH ;

MCNEIL, J ;

PRITCHARD, E ;

LOUIS, WJ .

JOURNAL OF PHARMACEUTICAL SCIENCES, 1981, 70 (09) :1030-1032

← 1 2 3 4 →